AI Transparency Report
Confidential Help For Alcohol And Drug Inc demonstrates consistent operational activity with revenues generally exceeding or closely matching expenses over the past decade. For instance, in 2023, revenue was $2,065,703 against expenses of $2,038,039, indicating a slight surplus. However, there have been periods of deficit spending, such as in 2022 where expenses ($1,892,048) exceeded revenue ($1,757,940). The organization's assets have shown significant fluctuation, with a notable increase from $650,617 in 2021 to $1,681,957 in 2023, alongside a substantial rise in liabilities from $52,855 to $1,190,639 in the same period. This suggests potential expansion or investment activities, but also an increased debt burden.
The organization's financial health appears stable, with sufficient assets to cover liabilities in most recent years, though the increasing liabilities warrant attention. The consistent reporting of 0% officer compensation across all available filings suggests either a volunteer-led executive team or that compensation is reported under other expense categories, which could impact transparency regarding leadership costs. Without a detailed breakdown of program, administrative, and fundraising expenses, it's challenging to fully assess spending efficiency, but the overall trend of expenses closely tracking revenue suggests that most funds are being utilized for operations rather than accumulating large surpluses.
Transparency regarding executive compensation is high, as 0% officer compensation is reported. However, the lack of detailed expense breakdowns in the provided data limits a full assessment of spending efficiency across different categories. The significant increase in both assets and liabilities from 2021 to 2023 indicates active financial management, but also points to a more leveraged financial position. Further details on the nature of these liabilities would provide greater insight into the organization's financial strategy and risk profile.